BP, Cardiovascular Disease, and Death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial

The optimal BP level in kidney transplant recipients remains uncertain. This post hoc analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial cohort assessed associations of BP with a pooled cardiovascular disease (CVD) outcome and with all-cause mortality. In 34...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Carpenter, Myra A., John, Alin, Weir, Matthew R., Smith, Stephen R., Hunsicker, Lawrence, Kasiske, Bertram L., Kusek, John W., Bostom, Andrew, Ivanova, Anastasia, Levey, Andrew S., Solomon, Scott, Pesavento, Todd, Weiner, Daniel E.
Format: Artigo
Langue:Inglês
Publié: American Society of Nephrology 2014
Sujets:
Clinical Epidemiology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073424/
https://ncbi.nlm.nih.gov/pubmed/24627349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013040435
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires